More Post from the Author
- H12025 global IPO activity shows resilience amid market volatility, says EY
- Kilsar Raises $3.7M to Revolutionize Maintenance & Maintenance Training with AI
- Digital Campers, Pet Parents, and a Tent Camping Revival: Newbook Report Reveals What's Next for RV & Camping in 2025
- Advantech stellt AMAX IoT-Steuerungsplattformen mit deterministischer Echtzeitleistung und Flexibilitt vor
- Resideo To Release Second Quarter 2025 Financial Results on August 5, 2025
AdventHealth Tampa is first in Tampa Bay to offer implantable chemotherapy pump for patients with metastatic colorectal cancer
Published on Wed 19 Mar 2025 9:40:06 UTC

Hepatic Artery Infusion therapy delivers treatment directly tometastatic tumors in the liver, while minimizing the potential for systemic side effects
TAMPA, Fla., March 18, 2025 /PRNewswire/ -- AdventHealth Tampa is the first in the Tampa Bay area to offer a powerful new pump-based treatment option for colorectal cancer that has spread to the liver and for a rare form of cancer that forms in bile ducts within the liver called intrahepatic cholangiocarcinoma.
Hepatic Artery Infusion (HAI) therapy uses a pump that is implanted just below the skin in a patient's abdominal wall to deliver medicine directly to the liver through the hepatic artery, maximizing drug delivery to the tumors without adding systemic side effects.
More Post from the Author
- H12025 global IPO activity shows resilience amid market volatility, says EY
- Kilsar Raises $3.7M to Revolutionize Maintenance & Maintenance Training with AI
- Digital Campers, Pet Parents, and a Tent Camping Revival: Newbook Report Reveals What's Next for RV & Camping in 2025
- Advantech stellt AMAX IoT-Steuerungsplattformen mit deterministischer Echtzeitleistung und Flexibilitt vor
- Resideo To Release Second Quarter 2025 Financial Results on August 5, 2025